Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omto.2023.08.009
PubMed Identifier: 37663131
Publication URI: http://europepmc.org/abstract/MED/37663131
Type: Journal Article/Review
Volume: 30
Parent Publication: Molecular therapy oncolytics
ISSN: 2372-7705